These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 2335602)
1. Monitoring liver tumor therapy with [18F]FDG positron emission tomography. Nagata Y; Yamamoto K; Hiraoka M; Abe M; Takahashi M; Akuta K; Nishimura Y; Jo S; Masunaga S; Kubo S J Comput Assist Tomogr; 1990; 14(3):370-4. PubMed ID: 2335602 [TBL] [Abstract][Full Text] [Related]
2. [Evaluation of the effect of treatment in patients with liver tumors using 18F-fluorodeoxyglucose PET]. Okazumi S; Enomoto K; Ozaki M; Yamamoto H; Yoshida M; Abe Y; Takayama W; Yamada S; Isono K; Imazeki K Kaku Igaku; 1989 Jun; 26(6):793-7. PubMed ID: 2796006 [TBL] [Abstract][Full Text] [Related]
3. Increased accumulation of 2-deoxy-2-[18F]Fluoro-D-glucose in liver metastases from colon carcinoma. Yonekura Y; Benua RS; Brill AB; Som P; Yeh SD; Kemeny NE; Fowler JS; MacGregor RR; Stamm R; Christman DR; Wolf AP J Nucl Med; 1982 Dec; 23(12):1133-7. PubMed ID: 6982967 [TBL] [Abstract][Full Text] [Related]
4. New approach to clinical evaluation of cancer chemotherapy using positron emission tomography with 18FDG (2-deoxy-2-[18F]fluoro-D-glucose). Takahashi H; Yamaguchi K; Wakui A; Maeda S; Yang PK; Ito M; Matsuzawa T; Fukuda H; Ido T Sci Rep Res Inst Tohoku Univ Med; 1986 Dec; 33(1-4):38-43. PubMed ID: 3498212 [No Abstract] [Full Text] [Related]
5. [Validity of positron emission tomography (PET) using 2-deoxy-2-[18F]fluoro-D-glucose (FDG) in patients with renal cell carcinoma (preliminary report)]. Kawamura J; Hida S; Yoshida O; Yonekura Y; Senda M; Yamamoto K; Saji H; Fujita T; Konishi J Kaku Igaku; 1988 Oct; 25(10):1143-8. PubMed ID: 3265450 [No Abstract] [Full Text] [Related]
7. High [18F]FDG uptake in primary cerebral lymphoma: a PET study. Kuwabara Y; Ichiya Y; Otsuka M; Miyake Y; Gunasekera R; Hasuo K; Masuda K; Takeshita I; Fukui H J Comput Assist Tomogr; 1988; 12(1):47-8. PubMed ID: 3257221 [TBL] [Abstract][Full Text] [Related]
8. Identification of early recurrence of primary central nervous system tumors by [18F]fluorodeoxyglucose positron emission tomography. Glantz MJ; Hoffman JM; Coleman RE; Friedman AH; Hanson MW; Burger PC; Herndon JE; Meisler WJ; Schold SC Ann Neurol; 1991 Apr; 29(4):347-55. PubMed ID: 1929205 [TBL] [Abstract][Full Text] [Related]
9. Ringlike uptake of [18F]FDG in brain abscess: a PET study. Sasaki M; Ichiya Y; Kuwabara Y; Otsuka M; Tahara T; Fukumura T; Gunasekera R; Masuda K J Comput Assist Tomogr; 1990; 14(3):486-7. PubMed ID: 2335626 [No Abstract] [Full Text] [Related]
10. High [18F]-fluorodeoxyglucose uptake in abdominal abscesses: a PET study. Tahara T; Ichiya Y; Kuwabara Y; Otsuka M; Miyake Y; Gunasekera R; Masuda K J Comput Assist Tomogr; 1989; 13(5):829-31. PubMed ID: 2789238 [TBL] [Abstract][Full Text] [Related]
11. Work in progress: [18F] fluorodeoxyglucose and positron emission tomography in the evaluation of radiation necrosis of the brain. Patronas NJ; Di Chiro G; Brooks RA; DeLaPaz RL; Kornblith PL; Smith BH; Rizzoli HV; Kessler RM; Manning RG; Channing M; Wolf AP; O'Connor CM Radiology; 1982 Sep; 144(4):885-9. PubMed ID: 6981123 [TBL] [Abstract][Full Text] [Related]
12. Assessment of response to cancer therapy using fluorine-18-fluorodeoxyglucose and positron emission tomography. Ichiya Y; Kuwabara Y; Otsuka M; Tahara T; Yoshikai T; Fukumura T; Jingu K; Masuda K J Nucl Med; 1991 Sep; 32(9):1655-60. PubMed ID: 1880564 [TBL] [Abstract][Full Text] [Related]
13. Differentiation of residual or recurrent tumors from post-treatment changes with F-18 FDG PET. Kim EE; Chung SK; Haynie TP; Kim CG; Cho BJ; Podoloff DA; Tilbury RS; Yang DJ; Yung WK; Moser RP Radiographics; 1992 Mar; 12(2):269-79. PubMed ID: 1561416 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of liver tumors using fluorine-18-fluorodeoxyglucose PET: characterization of tumor and assessment of effect of treatment. Okazumi S; Isono K; Enomoto K; Kikuchi T; Ozaki M; Yamamoto H; Hayashi H; Asano T; Ryu M J Nucl Med; 1992 Mar; 33(3):333-9. PubMed ID: 1311035 [TBL] [Abstract][Full Text] [Related]